ASSOCIATION FOR MULTIPLE ENDOCRINE NEOPLASIA DISORDERS
AMEND PROVIDES SUPPORT AND INFORMATION TO PATIENTS FAMILIES AND CARERS AFFECTED BY THE RARE GENETIC DISORDERS MULTIPLE ENDOCRINE NEOPLASIA, AS WELL AS TO THOSE WITH ASSOCIATED FAMILIAL AND SPORADIC TUMOURS. AMEND AIMS TO PROMOTE GREATER KNOWLEDGE OF THE BEST CARE AND MANAGEMENT OF MEN AND ASSOCIATED TUMOUR PATIENTS AMONGST THE MEDICAL PROFESSION.
Objects
TO RELIEVE PEOPLE WHO SUFFER FROM MULTIPLE ENDOCRINE NEOPLASIA (M.E.N.) OF ALL TYPES, THEIR FAMILIES, FRIENDS AND CARERS BY ALL OR ANY OF THE FOLLOWING MEANS:(1) ACTING AS A RELIABLE AND ACCURATE SOURCE OF INFORMATION FOR THE PUBLIC CONCERNING M.E.N. AND ITS ASSOCIATED SPORADIC GROWTHS, BY:(A) WORKING WITHIN THE APPROVAL OF MEMBERS OF THE MEDICAL PROFESSION WHO ARE DIRECTLY INVOLVED IN THE TREATMENT OF AND RESEARCH INTO M.E.N.(B) COLLECTING, COLLATING AND DISTRIBUTING APPROPRIATE AND APPROVED INFORMATION.(C) PRODUCING THE CHARITY’S OWN PATIENT-AIMED APPROVED INFORMATION.(2) PROMOTING A WIDER KNOWLEDGE OF THE ILLNESS AMONG THE MEDICAL PROFESSION TO ASSIST IN EARLY AND ACCURATE DIAGNOSIS.(3) PROVIDING RELIABLE AND ACCURATE INFORMATION WITH REGARD TO GENETIC TESTING FOR PEOPLE WITH M.E.N. AND ITS ASSOCIATED FAMILIAL GROWTHS, THEIR FAMILIES, FRIENDS AND CARERS.(4) PROVIDING EMOTIONAL SUPPORT TO PATIENTS, THEIR FAMILIES, FRIENDS AND CARERS IN THE FORM OF CONTACT WITH OTHERS IN SIMILAR SITUATIONS IN ORDER TO FACILITATE THE SHARING OF EXPERIENCES.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a deficit of £8,963 for the year ended 31 December 2025, an improvement on the prior year's deficit of £10,843, despite a decrease in total incoming resources to £82,239. Per the trustees' report, unrestricted reserves stood at £72,949, which exceeds the stated policy target of a minimum £60,000, and the trustees consider there are no material uncertainties regarding the charity's ability to continue as a going concern.
What the accounts disclose
“In 2024, the Trustees reviewed and amended the Financial Reserves Policy to state that they considered it prudent to hold a minimum reserve of £60,000, including £10,000 permanently maintained on demand, to ensure that AMEND’s core activities could continue for at least six months in the event of unforeseen financial difficulties.” — page 8
Policies the charity declares
- Complaints handling
- Complaints policy and procedures
- Financial reserves policy and procedures
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/12/2025
- Volunteers: 18
Self-declared on the annual return for the financial year ending 31/12/2024
- Volunteers: 29
Self-declared on the annual return for the financial year ending 31/12/2023
- Volunteers: 30
Funders the charity credits
- The Houghton Dunn Charitable Trust
- Rezolute Inc.
Trustees
- Andrew Price
- Dr John Ayuk
- GILL MASTERS
- Gemma Swindells
- Graeme Cohen
- Lauren Wheeler ACA
- Miriam Asia
- PROFESSOR KARIM MEERAN
- Robert Millinship
- Sarah Norman
- Shahab Khan
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £82k | £91k |
| 31/12/2024 | £95k | £106k |
| 31/12/2023 | £81k | £112k |
| 31/12/2022 | £130k | £139k |
| 31/12/2021 | £93k | £130k |
Common questions
Is ASSOCIATION FOR MULTIPLE ENDOCRINE NEOPLASIA DISORDERS financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a deficit of £8,963 for the year ended 31 December 2025, an improvement on the prior year's deficit of £10,843, despite a decrease in total incoming resources to £82,239. Per the trustees' report, unrestricted reserves stood at £72,949, which exceeds the stated policy target of a minimum £60,000, and the trustees consider there are no material uncertainties regarding the charity's ability to continue as a going concern. Its FY2025 accounts were independently examined.
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| The National Lottery Community Fund | 16/09/2022 | £9k | Peer Support in the Rare Endocrine Disease Community |
| UK government | 28/09/2020 | £9k | Coronavirus Community Support Fund |
| The National Lottery Community Fund | 15/08/2012 | £123k | Project Superhero |
| The National Lottery Community Fund | 11/11/2010 | £7k | AMEND Roadshow |
Charities like this
- ASSOCIATION OF BREAST SURGERY
- ADAPT (NORTH EAST)
- NEUROENDOCRINE CANCER UK
- BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS
- NEOTREE
- ANAND & SETHI FAMILY CHARITY TRUST
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| ASSOCIATION FOR MULTIPLE ENDOCRINE NEOPLASIA DISORDERS | £82k | — | — | unclear | — | no doubt |
| ASSOCIATION OF BREAST SURGERY | £1.3m | — | — | unclear | — | no doubt |
| ADAPT (NORTH EAST) | £1.0m | — | 0 | below | — | no doubt |
| NEUROENDOCRINE CANCER UK | £696k | — | — | unclear | — | no doubt |
| BRITISH ASSOCIATION OF ENDOCRINE AND THYROID SURGEONS | £232k | — | — | above | — | no doubt |
| NEOTREE | £1.2m | — | 0 | above | — | no doubt |